Sleep difficulties affect 50-80% of autistic children, compared to 25-40% of neurotypical peers (Richdale & Schreck, 2009). Common issues include delayed sleep onset, night waking, and early morning rising. First-line treatment is behavioural sleep intervention (sleep hygiene, bedtime routines, stimulus fading). Melatonin (0.5-5mg) is the most studied pharmacological option, with a Cochrane review by Rossignol & Frye (2011) showing improved sleep onset latency by an average of 28 minutes.
Start with the short answer, then reveal deeper context where helpful.
Sleep difficulties in autistic children have both biological and behavioural roots. Research suggests differences in melatonin production and circadian rhythm regulation, sensory sensitivities that interfere with settling, co-occurring anxiety, and difficulty with transitions (including the transition from wakefulness to sleep). Richdale & Schreck (2009) found that 50-80% of autistic children experience clinically significant sleep problems.
The American Academy of Pediatrics recommends behavioural sleep interventions as first-line treatment. These include: consistent bedtime routines, sleep hygiene optimization (dark room, cool temperature, screen removal 60+ minutes before bed), graduated extinction or stimulus fading techniques, and visual schedules for the bedtime sequence. BCBAs and psychologists can design individualized behavioural sleep programs.
Sleep difficulties in autistic children have both biological and behavioural roots. Research suggests differences in melatonin production and circadian rhythm regulation, sensory sensitivities that interfere with settling, co-occurring anxiety, and difficulty with transitions (including the transition from wakefulness to sleep). Richdale & Schreck (2009) found that 50-80% of autistic children experience clinically significant sleep problems.
Poor sleep has cascading effects: increased daytime challenging behaviours, reduced learning capacity, worsened sensory sensitivities, and significant family stress. Parents of autistic children with sleep problems report higher rates of caregiver burnout and mental health difficulties. Addressing sleep is therefore a high-priority intervention target.
The American Academy of Pediatrics recommends behavioural sleep interventions as first-line treatment. These include: consistent bedtime routines, sleep hygiene optimization (dark room, cool temperature, screen removal 60+ minutes before bed), graduated extinction or stimulus fading techniques, and visual schedules for the bedtime sequence. BCBAs and psychologists can design individualized behavioural sleep programs.
When behavioural approaches alone are insufficient, melatonin is the most-studied pharmacological intervention. A Cochrane-style review by Rossignol & Frye (2011) found melatonin reduced sleep onset latency by an average of 28 minutes and increased total sleep time by approximately 48 minutes. Dosing typically ranges from 0.5-5mg, 30 minutes before desired bedtime. Consult your child's physician before starting melatonin or any medication.
Research
Richdale & Schreck (2009), "Sleep Problems in Autism: Prevalence, Nature, and Possible Biopsychosocial Aetiologies," Sleep Medicine Reviews, 13(6), 403-411
Research
Rossignol & Frye (2011), "Melatonin in ASD: A Systematic Review and Meta-Analysis," Developmental Medicine & Child Neurology, 53(9), 783-792
40-50% of autistic children experience clinical anxiety. Learn about adapted CBT, medication options, and coping strategies available in Ontario.
Positive behaviour support plans are created by BCBAs and are core to OAP clinical services. Learn what they include, who creates them, and how OAP covers them.
OT-based sensory integration therapy addresses sensory processing differences in autistic children. Learn about the evidence, OAP coverage, and what to expect.
Commitment to Accuracy: Our data is verified against official government reports (FAO, MCCSS), peer-reviewed scientific literature, and accessible public records. Last updated: March 24, 2026.
Verified Facts
88,175, children are registered in the Ontario Autism Program
23.4%, Only 20,666 children have active funding agreements () — less than one in four
WHO recommends accessible, community-based early interventions for children with autism — timely evidence-based psychosocial interventions improve communication and social engagement